Develop medicines through application experiences

The future of medical research: MEDIKURA and patient-reported outcome measures

XO Life (formerly Medikura) is revolutionizing drug monitoring and treatment optimization through its innovative real-world evidence platform. Patients, doctors and pharmaceutical companies benefit from a rapid and precise exchange of data on the effects and side effects of drugs. Patients use the platform to report on their treatment processes in real time, which forms an important basis for research and clinical diagnostics. The use of “Patient-Reported Outcome Measures” (PROMs) enables users to self-assess their health status and share important information directly with healthcare professionals and research companies. This method supports the optimization of drugs and medical treatments and minimizes the risk of incorrect medications and side effects.

More than 2,000 patients have already recognized the benefits of the platform and are continuously providing data that is crucial for risk-benefit assessments and the development of more effective treatment methods. The platform meets the highest data protection standards in accordance with the General Data Protection Regulation and enables users to securely share their experiences.

The digital transformation through XO Life is a central pillar of future-oriented medical research and makes a significant contribution to increasing drug safety. Scientists and doctors, including from LMU Munich and Heidelberg University, confirm the importance of this technology for pharmacovigilance and public health research.